SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 1,076+0.5%Dec 22 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack Stirling who wrote (235)5/28/1998 10:42:00 PM
From: James Baker  Read Replies (1) of 642
 
Jack I have no idea why you thought that - wish it were true. Sad truth for us LLY owners is that Evista is approved for osteoporosis prevention only at this time. Studies to fully prove the breast cancer prevention and heart disease prevention benefits of E are probably years away.
Now that said the drug is approved and on the market and some patients and docs may decide to run with the info as presented at the oncology meeting s that E prevents 60-70% of breast cancers in the general population of post-menapausal women. that makes it a very attractive choice for osteop. prevention indeed.
Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext